Healthcare -
Biotechnology - NASDAQ - US
$ 30.91
-1.4 %
$ 2.01 B
Market Cap
-10.37
P/E
KYMR - GROSS PROFIT
Gross Profit KYMR - Kymera Therapeutics, Inc.
-110 M
LAST VALUE
-60.27%
2 YEAR CAGR
-251.81%
5 YEAR CAGR
0.00%
10 YEAR CAGR